Ossur hf (OSSR) - Financial and Strategic SWOT Analysis Review

Ossur hf (OSSR) - Financial and Strategic SWOT Analysis Review


- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Ossur hf (Ossur) is an orthopedic device company. It designs, develops, manufactures, and sells prosthetics, and bracing and support products. The company also has vast expertise in compression therapy. It offers ankle and foot supports, neck and spine support products and walkers; knee braces, compression socks, thighs and bandages; and an extensive range of premium lower limb prosthetics, including liners, knees, and feet. It has manufacturing facilities in the Americas, Europe, the Middle East and Africa, and Asia-Pacific. The company distributes its products through its subsidiaries and also through a network of distributors. Ossur is headquartered in Reykjavik, Iceland.

Ossur hf Key Recent Developments

Apr 23,2024: Embla Medical Announces Interim Report Q1 2024
Apr 04,2024: Correction: Notice to attend the Annual General Meeting of Vitrolife AB (publ)
Feb 21,2024: Ossur hf: Annual General Meeting 13 March 2024
Feb 21,2024: Össur hf: Össur establishes new parent organization to be named Embla Medical

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Ossur hf - Key Facts
Ossur hf - Key Employees
Ossur hf - Key Employee Biographies
Ossur hf - Major Products and Services
Ossur hf - History
Ossur hf - Company Statement
Ossur hf - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Ossur hf - Business Description
Business Segment: Bracing and Supports
Overview
Performance
Business Segment: Patient Care
Overview
Performance
Business Segment: Prosthetics
Overview
Performance
Geographical Segment: Americas
Performance
Geographical Segment: APAC
Performance
Geographical Segment: EMEA
Performance
R&D Overview
Ossur hf - Corporate Strategy
Ossur hf - SWOT Analysis
SWOT Analysis - Overview
Ossur hf - Strengths
Ossur hf - Weaknesses
Ossur hf - Opportunities
Ossur hf - Threats
Ossur hf - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Ossur hf, Medical Equipment, Deals By Year, 2018 to YTD 2024
Ossur hf, Medical Equipment, Deals By Type, 2018 to YTD 2024
Ossur hf, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 23, 2024: Embla Medical Announces Interim Report Q1 2024
Apr 04, 2024: Correction: Notice to attend the Annual General Meeting of Vitrolife AB (publ)
Feb 21, 2024: Ossur hf: Annual General Meeting 13 March 2024
Feb 21, 2024: Össur hf: Össur establishes new parent organization to be named Embla Medical
Jan 30, 2024: Össur hf: Interim Report Q4 2023
Oct 24, 2023: Össur hf.: Össur hf: Interim report Q3 2023
Oct 24, 2023: Ossur Hf: Interim Report Q3 2023
Jul 25, 2023: Ossur hf : Interim Report Q2 2023
Jun 15, 2023: Ossur hf: Ossur Appoints Lukas Marklin as Chief Operating Officer
Apr 25, 2023: Össur hf.: Össur hf: Interim Report Q1 2023
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Ossur hf, Key Facts
Ossur hf, Key Employees
Ossur hf, Key Employee Biographies
Ossur hf, Major Products and Services
Ossur hf, History
Ossur hf, Subsidiaries
Ossur hf, Key Competitors
Ossur hf, Ratios based on current share price
Ossur hf, Annual Ratios
Ossur hf, Annual Ratios (Cont...1)
Ossur hf, Annual Ratios (Cont...2)
Ossur hf, Interim Ratios
Ossur hf, Medical Equipment, Deals By Year, 2018 to YTD 2024
Ossur hf, Medical Equipment, Deals By Type, 2018 to YTD 2024
Ossur hf, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Ossur hf, Performance Chart (2019 - 2023)
Ossur hf, Ratio Charts
Ossur hf, Medical Equipment, Deals By Year, 2018 to YTD 2024
Ossur hf, Medical Equipment, Deals by Type, 2018 to YTD 2024

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings